Brief: Neurovive reports positive pre-clinical results for NVP018
01/11/2016 07:30
Nov 1 (Reuters) - Neurovive Pharmaceutical AB NVP.ST
* Says reports positive pre-clinical results in NASH -
(non-alcoholic steatohepatitis, a progressive disease that can
lead to liver cirrhosis and the development of hepatocellular
carcinoma)
* Says the present data shows that NVP018 prevents fibrosis
development in a well-validated experimental model of NASH
* Says further experimental activities with NVP018 within
NASH are ongoing
Source text for Eikon: ID:nWkrjE4208
Further company coverage: NVP.ST
(Stockholm Newsroom)
((stockholm.newsroom@thomsonreuters.com; +46 (0)8-700 10 10;))